Tag:
Mitsubishi Tanabe Pharma
Latest Headlines
Latest Headlines
Mitsubishi Tanabe Pharma taps Synageva for orphan disease R&D
Rare disease know-how remains a hot commodity. Aiming to gain access to orphan disease and protein drug-making expertise, Mitsubishi Tanabe Pharma has struck an R&D deal with Synageva BioPharma.
Tanabe cuts jobs as it focuses on biologics
Mitsubishi Tanabe Pharma announced today that the company is closing Tanabe Research Labs U.S.A., the La Jolla-based labs it's occupied since the early 1990s. In the process, it's also cutting 35
Cytochroma gains CDN $45M, licensing deal
Canada's Cytochroma has garnered CDN $45 million in a Series C round led by Mitsubishi Tanabe Pharma Corporation. A group of existing investors including VentureLink Brighter Future Fund, Caisse de
